Correction to: hdac class i inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via foxm1 modulation

HIGHLIGHTS

SUMMARY

    Fig 3e: in the upper panel, the standard deviation lines and statistically lines originally overlapped; this has been corrected. When established tumors were palpable, mice were treated with vehicles or domatinostat (20 mg/Kg 5 days/ week, per os) alone and in combination with gemcitabine (weekly 25 mg/Kg, i.p.) and abraxane (weekly 20 mg/Kg, i.p.) In the Availability of data and materials section, it has been updated to: All data generated or analyzed during this study are included in this published article or in supplementary information. Cell Biology and Biotherapy . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?